Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.

Literature DB >> 17709463

TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.

Frédéric Robin¹, Julien Delmas, Amélie Brebion, Damien Dubois, Jean-Michel Constantin, Richard Bonnet.

Abstract

TEM-158 was found to include the substitutions previously observed for TEM-12 and TEM-35. This enzyme presented hydrolytic activity against ceftazidime and a high level of resistance against clavulanate, which can alter its detection. Its discovery highlights the need for accurate detection methods.

Entities: Chemical

Mesh：

Substances：

Year: 2007 PMID： 17709463 PMCID： PMC2151416 DOI： 10.1128/AAC.00614-07

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

10 in total

1. Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.

Authors: V Leflon-Guibout; B Heym; M Nicolas-Chanoine
Journal: Antimicrob Agents Chemother Date: 2000-11 Impact factor: 5.191

2. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Authors: C Neuwirth; S Madec; E Siebor; A Pechinot; J M Duez; M Pruneaux; M Fouchereau-Peron; A Kazmierczak; R Labia
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

Review 3. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors: E B Chaïbi; D Sirot; G Paul; R Labia
Journal: J Antimicrob Chemother Date: 1999-04 Impact factor: 5.790

4. CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.

Authors: Frédéric Robin; Julien Delmas; Maryse Archambaud; Cédric Schweitzer; Catherine Chanal; Richard Bonnet
Journal: Antimicrob Agents Chemother Date: 2006-07 Impact factor: 5.191

5. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.

Authors: Frédéric Robin; Julien Delmas; Cédric Schweitzer; Olivier Tournilhac; Olivier Lesens; Catherine Chanal; Richard Bonnet
Journal: Antimicrob Agents Chemother Date: 2007-01-12 Impact factor: 5.191

6. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.

Authors: D Sirot; C Recule; E B Chaibi; L Bret; J Croize; C Chanal-Claris; R Labia; J Sirot
Journal: Antimicrob Agents Chemother Date: 1997-06 Impact factor: 5.191

7. TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).

Authors: F Robin; J Delmas; C Chanal; D Sirot; J Sirot; R Bonnet
Journal: Antimicrob Agents Chemother Date: 2005-11 Impact factor: 5.191

8. Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genes.

Authors: C Chanal; D Sirot; H Malaure; M C Poupart; J Sirot
Journal: Antimicrob Agents Chemother Date: 1994-10 Impact factor: 5.191

9. A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae.

Authors: J Fiett; A Pałucha; B Miaczyńska; M Stankiewicz; H Przondo-Mordarska; W Hryniewicz; M Gniadkowski
Journal: Antimicrob Agents Chemother Date: 2000-06 Impact factor: 5.191

10. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.

Authors: Laurent Poirel; Hedi Mammeri; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2004-12 Impact factor: 5.191